Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07874542 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Plasma DNA Methylation for Preoperative Classification of Renal Masses

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
RenJi Hospital
190 trials monitored
See 2 trials at risk
Kidney Cancer
889 trials monitored
See 68 trials at risk
METH-RENAL is a prospective observational diagnostic development and threshold-setting study in adults with a renal mass scheduled for partial or radical nephrectomy. Peripheral blood is collected before surgery, and postoperative histopathology serves as the reference standard. The study will develop and internally validate a plasma DNA methylation classifier and lock the final marker panel, algorithm, and positivity cut-off for a subsequent independent prospective multicenter validation study.
Trial Details
NCT Number NCT07874542
Lead Sponsor RenJi Hospital
Collaborators: Sun Yat-Sen University Cancer Center
Conditions
(from sponsor)		 Renal Cell Carcinoma, Benign Renal Mass
Related terms Carcinoma, Renal Cell
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov